Screener / SEC EDGAR /CIK 0001520262 /10-K filed Feb 25, 2026, compared with Feb 12, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Alkermes plc. ALKS

Compare with peers Embed
Insider trades since May 20, 2026

6 insiders sold $5.7M on the market, none bought

Form 4
Bought on the market $0 0 trades
Sold on the market $5.7M 16 trades by 6 insiders
Sold under a 10b5-1 plan 48% of the value sold, under a plan set up in advance
Traded the most nancy lynn MD snyderman $2.2M Director

Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.

A year of insider trades, day by day

Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025

NovDecJanFebMarAprMayJunJulAugSepOctNov Mon Wed Fri

$0 bought on 0 days, $5.7M sold on 12 days. Each square is a day; click one for its Form 4.

SoldBought

Buys and sales by insider

Who traded · Form 4, added up

InsiderBoughtSoldLatest
nancy lynn MD snyderman
Director
-$2.2M Aug 3, 2026
Craig C. Hopkinson
EVP R&D, Chief Medical Officer
-$1.7M Sep 1, 2026
Samuel Joseph Parisi
VP, Finance (Interim PAO)
-$687K May 29, 2026
David Joseph Gaffin
EVP, CLO, Alkermes, Inc.
-$571K Nov 3, 2026
Christian Todd Nichols
SVP, Chief Commercial Officer
-$373K Aug 17, 2026
Christopher I. Wright
Director
-$90K Jun 12, 2026

Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.

Trade by trade, newest first

Every trade · each date links to its Form 4

Of 16 open-market sales by officers and directors, 3 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.

DateInsiderTypeSharesValue
Nov 3, 2026 David Joseph Gaffin Sale (10b5-1) -2,035 94K
Oct 2, 2026 David Joseph Gaffin Sale (10b5-1) -2,034 83K
Sep 3, 2026 David Joseph Gaffin Sale (10b5-1) -2,034 98K
Sep 1, 2026 Craig C. Hopkinson Sale (10b5-1) -9,000 423K
Aug 17, 2026 Christian Todd Nichols Sale (10b5-1) -6,912 340K
Aug 17, 2026 Christian Todd Nichols Sale (10b5-1) -664 33K
Aug 3, 2026 David Joseph Gaffin Sale (10b5-1) -2,034 99K
Aug 3, 2026 Craig C. Hopkinson Sale (10b5-1) -9,000 437K
Aug 3, 2026 nancy lynn MD snyderman Sale -44,472 2.2M
Jul 6, 2026 David Joseph Gaffin Sale (10b5-1) -2,034 110K
Jul 1, 2026 Craig C. Hopkinson Sale (10b5-1) -8,300 427K
Jul 1, 2026 Craig C. Hopkinson Sale (10b5-1) -700 36K
Jun 12, 2026 Christopher I. Wright Sale (10b5-1) -2,000 90K
Jun 4, 2026 David Joseph Gaffin Sale (10b5-1) -2,034 88K
Jun 1, 2026 Craig C. Hopkinson Sale (10b5-1) -9,000 375K
May 29, 2026 Samuel Joseph Parisi Sale -16,217 687K
Show the other 1 trades

Sources

Form 4s from SEC's filing index. An insider files one within two business days of a trade.

Also

Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ALKS/export.csv") into a cell.

Next:Insider selling plans
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.